Navigation Links
Genoptix Reports Strong Full-Year Financial Results for 2008 and Raises Guidance for 2009
Date:2/26/2009

for 2007.

Net income for the full-year 2008 was $31.4 million, up from $13.4 million for the full-year 2007. Diluted EPS for 2008 was $1.78, based on 17.7 million weighted average common shares outstanding, including net benefits resulting primarily from the recognition of deferred tax assets during the year.

The Company completed its IPO on November 2, 2007. On a pro forma basis, assuming conversion of all outstanding preferred stock, diluted EPS for the quarter and year ended December 31, 2007 would have been $0.29 and $0.99, respectively (see "Pro Forma Net Income Per Share" table below).

As of December 31, 2008, the Company's total cash, cash equivalents and investment securities were $107.1 million, of which $4.1 million was classified as long-term. For the full-year 2008, cash generated from operations was $28.2 million, while purchases of capital equipment for the same period totaled $9.6 million. The year ended with bad debt expense at approximately 3% of total revenues and days sales outstanding of 53 days.

"We accomplished a great deal in 2008, our first full year operating as a public company. From our recent facilities expansion and the move into new administrative offices to our successful recruiting efforts and hiring of 126 new employees, managing growth to ensure our continued high quality service has been our central focus," said Sam Riccitelli, Genoptix EVP and COO. "We will continue to develop and strengthen our organization by hiring key mid-level management and adding the structure necessary to support our sales team and operational staff. Throughout 2008, we welcomed 11 hematopathologists to our Cartesian Medical Group, meeting our goal of housing 25 physicians at year-end. In 2008, our sales team expanded to a total of 65 people, 55 of which are field sales representatives who will help us to pursue our objective of capturing 15 - 20% of the bone marrow market share
'/>"/>

SOURCE Genoptix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Genoptix Announces Participation at the RBC Capital Markets 2008 Healthcare Conference
2. Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008
3. Genoptix Announces the Addition of New Members to Board of Directors
4. Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008
5. Genoptix Reports Strong Financial Results for First Quarter 2008
6. Genoptix Announces Participation at the Bank of America 2008 Healthcare Conference
7. Genoptix Announces 2008 Annual Stockholders Meeting and Date of Record
8. Genoptix Announces Participation at Lehman Brothers 11th Annual Global Health Care Conference
9. Genoptix Announces Participation at Cowen and Company 28th Annual Health Care Conference
10. Genoptix Announces Pricing of Secondary Public Offering
11. Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... By Steven Reinberg ... -- On the same day that President Barack Obama announced ... Africa,s Ebola crisis, the World Health Organization warned Tuesday that ... infections could start doubling every three weeks. Obama said ... offer medical and logistical support to beleaguered health care facilities ...
(Date:9/17/2014)... severe maternal morbidity amongst women in Australia is ... study published today (17 September) in BJOG: ... , Australians generally enjoy high standards of living; ... exist, in particular between indigenous and non indigenous ... the independent impact of socioeconomic position on severe ...
(Date:9/17/2014)... of a perfectly poured glass of wine leads to an ... Denmark, have now developed a nanosensor that can mimic what ... measures how you experience the sensation of dryness in the ... they need to control a number of processes to bring ... in the wine bottle. An important part of the taste ...
(Date:9/17/2014)... 17, 2014 MarijuanaStock.net, a cannabis ... recently launched a “Video” section that contains important ... in the marijuana industry made available in video ... visitor is given access to numerous interviews, news ... businesses and the issues they face. , ...
(Date:9/17/2014)... Fresh off their High Times Cannabis ... support of The Silver Tour, an educational non-profit effort ... benefits of medical marijuana. , Florida Buds, a Florida ... marijuana dispensary and treatment center, donated $1,000.00 to ... launch a statewide radio campaign in advance of Election ...
Breaking Medicine News(10 mins):Health News:Obama Steps Up Aid to Fight Ebola in West Africa 2Health News:Obama Steps Up Aid to Fight Ebola in West Africa 3Health News:New study examines the impact of socioeconomic position and maternal morbidity in Australia 2Health News:New study examines the impact of socioeconomic position and maternal morbidity in Australia 3Health News:Nanoscience makes your wine better 2Health News:Nanoscience makes your wine better 3Health News:MarijuanaStock.net Adds Business News Video Section to Their Website 2Health News:Florida Buds Supports Silver Tour 2
... Therapeutics Inc. (Nasdaq CM: CRTX), a specialty pharmaceutical company ... for the respiratory and related markets, today announced that ... Vice President, General Counsel and Secretary. In this ... team and manage its legal function and corporate governance ...
... ... Drug Administration approved the use of silicone implants for breast augmentation procedures in women over ... decision capped a controversy that spanned more than a decade, and one plastic surgeon ... , ...
... , ... 1-3 December at Olympia Grand Hall, London, ... across Mainland Europe with two brand new features -- The French ... France, and The European Librarians’ Theatre which hosts sessions on topical ...
... CHARLOTTE, N.C., Nov. 12 Even with the economy still ... - and in quite a creative way. , Southeast Pain ... Dec. 3 performance of "Grease" at Ovens Auditorium and giving ... , "We are committed to supporting our patients in ...
... INDIANAPOLIS, Nov. 12 Centerplate, the hospitality ... sports stadiums, announced today with the Capital Improvement ... investigation of Lucas Oil Stadium to immediately address ... facility operates as a model of operational excellence ...
... are highlights from the November issue of Mayo ... as often as you wish. Mayo Clinic ... Reprinting is allowed for a fee. Include the following ... www.bookstore.mayoclinic.com or call toll-free for subscription ...
Cached Medicine News:Health News:Cornerstone Therapeutics Appoints General Counsel 2Health News:Cornerstone Therapeutics Appoints General Counsel 3Health News:Valencia, California, Plastic Surgeon Weighs in on Silicone Breast Implants – 3 Years After FDA Approval 2Health News:Valencia, California, Plastic Surgeon Weighs in on Silicone Breast Implants – 3 Years After FDA Approval 3Health News:Valencia, California, Plastic Surgeon Weighs in on Silicone Breast Implants – 3 Years After FDA Approval 4Health News:Online Information 2009 Exhibition Focuses on Mainland Europe 2Health News:Online Information 2009 Exhibition Focuses on Mainland Europe 3Health News:Southeast Pain Care Provides Relief and Gives Back - Creatively 2Health News:Centerplate and the Capital Improvement Board Investigating Food Safety Violations at Lucas Oil Stadium to Ensure Highest Standards Achieved and Operational Excellence 2Health News:November 2009 Mayo Clinic Women's HealthSource Highlights Reducing Cancer Risk, Tips to Reduce Flatulence and Eating Nuts for Heart Health 2Health News:November 2009 Mayo Clinic Women's HealthSource Highlights Reducing Cancer Risk, Tips to Reduce Flatulence and Eating Nuts for Heart Health 3Health News:November 2009 Mayo Clinic Women's HealthSource Highlights Reducing Cancer Risk, Tips to Reduce Flatulence and Eating Nuts for Heart Health 4Health News:November 2009 Mayo Clinic Women's HealthSource Highlights Reducing Cancer Risk, Tips to Reduce Flatulence and Eating Nuts for Heart Health 5
(Date:9/17/2014)... 2014  Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... that address unmet medical needs in the areas ... agreement has been reached with the US Food ... a pivotal, Phase 3 clinical trial evaluating its ... cutaneous T-cell lymphoma (CTCL).  SGX301 ...
(Date:9/17/2014)... LAUSANNE , Switzerland , ... part of Debiopharm Group ™ , is proud to ... ™ instrument. Debiopharm Diagnostics is a long-time ... portfolio. Idylla ™ Biocartis, fully ... designed to offer physicians fast and easy access ...
(Date:9/16/2014)... Sept. 16, 2014 This report analyzes the worldwide ... the following Product Segments: SPECT Systems (Includes SPECT and SPECT/CT ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... and forecasts are provided for the period 2013 through 2020. ...
Breaking Medicine Technology:Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 2Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 3Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 4Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 5Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 6Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 7Debiopharm Diagnostics Portfolio Company Biocartis Ships its First Idylla Instrument 2Global Nuclear Medicine Imaging Equipment Industry 2Global Nuclear Medicine Imaging Equipment Industry 3Global Nuclear Medicine Imaging Equipment Industry 4Global Nuclear Medicine Imaging Equipment Industry 5Global Nuclear Medicine Imaging Equipment Industry 6Global Nuclear Medicine Imaging Equipment Industry 7Global Nuclear Medicine Imaging Equipment Industry 8Global Nuclear Medicine Imaging Equipment Industry 9Global Nuclear Medicine Imaging Equipment Industry 10Global Nuclear Medicine Imaging Equipment Industry 11Global Nuclear Medicine Imaging Equipment Industry 12Global Nuclear Medicine Imaging Equipment Industry 13Global Nuclear Medicine Imaging Equipment Industry 14Global Nuclear Medicine Imaging Equipment Industry 15Global Nuclear Medicine Imaging Equipment Industry 16Global Nuclear Medicine Imaging Equipment Industry 17Global Nuclear Medicine Imaging Equipment Industry 18Global Nuclear Medicine Imaging Equipment Industry 19Global Nuclear Medicine Imaging Equipment Industry 20Global Nuclear Medicine Imaging Equipment Industry 21Global Nuclear Medicine Imaging Equipment Industry 22Global Nuclear Medicine Imaging Equipment Industry 23Global Nuclear Medicine Imaging Equipment Industry 24Global Nuclear Medicine Imaging Equipment Industry 25Global Nuclear Medicine Imaging Equipment Industry 26
... 2011 Reportlinker.com announces that a new ... catalogue: Drug Delivery in ... companies http://www.reportlinker.com/p0203542/Drug-Delivery-in-Central-Nervous-System-Diseases---technologiesmarkets-and-companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ... The delivery of drugs to central nervous ...
... 30, 2011 Reportlinker.com announces that a ... its catalogue: Cardiovascular Drug ... http://www.reportlinker.com/p0203538/Cardiovascular-Drug-Delivery---technologiesmarkets-and-companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ... the cardiovascular system is different from delivery ...
Cached Medicine Technology:Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 3Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 4Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 5Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 6Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 7Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 8Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 9Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 10Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 11Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 12Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 13Cardiovascular Drug Delivery - Technologies, Markets and Companies 2Cardiovascular Drug Delivery - Technologies, Markets and Companies 3Cardiovascular Drug Delivery - Technologies, Markets and Companies 4Cardiovascular Drug Delivery - Technologies, Markets and Companies 5Cardiovascular Drug Delivery - Technologies, Markets and Companies 6Cardiovascular Drug Delivery - Technologies, Markets and Companies 7Cardiovascular Drug Delivery - Technologies, Markets and Companies 8Cardiovascular Drug Delivery - Technologies, Markets and Companies 9Cardiovascular Drug Delivery - Technologies, Markets and Companies 10Cardiovascular Drug Delivery - Technologies, Markets and Companies 11Cardiovascular Drug Delivery - Technologies, Markets and Companies 12Cardiovascular Drug Delivery - Technologies, Markets and Companies 13
... improves patient compliance, prevent skin breakdown ... user's anatomy, wicks moisture, and evenly ... shoulders and upper throacic. Fits upright ... airflow openings. Adjustable Occipital Support Strap™ ...
Wonderflex™ is a lined soft durometer silicone gel sheet. It is ideal for cushioning orthotic/prosthetic devices and offers protection from shock and sheer forces. Wonderflex can also be lamina...
... length 10" elastic binder has a variety of ... an abdominal binder for post-surgical dressings. It ... has been a loss of muscle tone. ... belt to prevent painful expansion of the chest ...
Designed to provide relief from chronic or acute back pain by unloading pressure off the lumbar discs and shifting pressure to the abdominal region...
Medicine Products: